Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.

Audrey Laroche,Delphine Garbay,Vanessa Chaire,Valérie Le Morvan,Agnès Neuville,François Bertucci,Sébastien Salas,Roberta Sanfilippo,Philippe Pourquier,Antoine Italiano

Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.

2014

Audrey Laroche
Delphine Garbay
Vanessa Chaire
Valérie Le Morvan
Agnès Neuville
François Bertucci
Sébastien Salas
Roberta Sanfilippo
Philippe Pourquier
Antoine Italiano

10598 Background: Trabectedin (T) has shown objective response and disease stabilisation in 5%–10% and 30-40% of unselected patients with advanced soft tissue sarcoma (STS) failing prior anthracycl...

Keywords:

Pathology
Trabectedin
Soft tissue sarcoma
Haplotype
Medicine
Oncology
predictive value
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations